ADOCIA a biotechnology company dedicated to protein delivery

  • Contact Us
  • Linkedin
  • RSS
  • LANGUAGES
    • English English
    • Français Français
  • Presentation
    • About Adocia
    • Founders
    • Management
    • Board of Directors
    • Team
    • Scientific Advisory Board
    • Symbol
  • Technology
    • BIOCHAPERONE®
    • Intellectual property
    • Publications
  • Products
    • Pipeline
    • BIOCHAPERONE® LISPRO
    • BIOCHAPERONE® COMBO
    • M1Pram
    • BIOCHAPERONE® GLUCAGON
    • BIOCHAPERONE® Gla GLP-1
    • BioChaperone® Glucagon GLP-1
    • Cell Therapy
  • Partnering
    • Licensing Opportunities
    • Contact
  • Financials
    • Home Investors
    • Regulated Information
    • Documentation
    • Shareholders
    • Shareholders meeting
    • Governance
    • Investors Contact
  • Careers
    • Working at Adocia
    • HR Policy
    • Spontaneous application
    • Offers
  • News & Events
    • Press Releases
    • Upcoming Events

Adocia’s Intellectual property

AdociaAdocia’s Intellectual property comprises around 47 patent families covering the scope of its research activities.

These families are made up of approximately 96 patent applications and 67 granted patents.

 

More precisely, Adocia’s portfolio consists mainly of patents and patent applications within the following fields:

  • Chronic Wound Healing, with 26 patents already granted
  • Insulin Therapy (diabetes), with 34 patents already granted
  • Monoclonal Antibodies (mAb), a new domain with 3 patents granted

In general, the filing strategy usually entails a first patent application to be filed in France, with a provisional US patent to be filed during pre-AIA (America Invents Act) time, and a PCT extension as well as, in certain cases, the filing of a regular patent application in the US.

Technology

  • BioChaperone®
  • Intellectual property
  • Publications

A la Une / Spotlight

  • In January, read Adocia’s article on M1Pram published in the Journal “Diabetes, Obesity and Metabolism”.

    The scientific journal “Diabetes, Obesity...
  • January 11: Adocia Pipeline and Perspective at the occasion of H.C.WAINWRIGHT BIOCONNECT 2021 CONFERENCE

    Gerard Soula Presentation at H.C. Wainwright Bi...

 

  • Home
  • Terms Of Use
  • Privacy Policy
  • Contact
ADOCIA a biotechnology company dedicated to protein delivery

Copyright ADOCIA © 2018

TOP